Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alignment Healthcare, Inc. (NASDAQ: ALHC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a Medicare Advantage-focused health insurer. Alignment files annual and quarterly reports, along with current reports on Form 8-K, that describe its financial condition, operations and key developments in its Medicare Advantage business.
Recent Form 8-K filings show that Alignment uses these reports to announce quarterly financial results and share information discussed with investors and analysts. For example, the company has filed 8-Ks to furnish press releases on second and third quarter results and to outline discussions of strategy, market position and preliminary CMS Star Ratings. These filings often reference non-GAAP measures such as adjusted gross profit and adjusted EBITDA, which are defined and reconciled to the most comparable GAAP measures in accompanying tables.
Alignment’s SEC filings also provide detail on revenue sources and expenses. Condensed consolidated statements of operations list earned premiums and other revenue, along with medical expenses, selling, general and administrative expenses, and depreciation and amortization. Balance sheet information includes medical expenses payable, long-term debt and stockholders’ equity, giving investors a structured view of the company’s capital and obligations.
Through this page, users can track ongoing 8-K disclosures related to earnings releases, guidance updates, investor presentations and other material events. Filings may also reference CMS Star Ratings, membership expectations and risk factors summarized in the company’s Form 10-K and other periodic reports. Stock Titan enhances access to these documents with AI-powered tools that help explain terminology, highlight key sections and summarize lengthy filings, allowing investors to more quickly understand how ALHC reports its performance, membership trends and risk profile.
Alignment Healthcare (ALHC) Form 144 summary: The filing notifies a proposed sale of 18,600 shares of common stock on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $269,886. The filing reports 198,031,417 shares outstanding. The shares were acquired on 03/26/2021 as pre-IPO shares issued in exchange for partnership units. The filing lists an approximate date of sale of 08/11/2025 and states there were no securities sold in the past three months. By signing the notice the seller represents they do not know of any undisclosed material adverse information about the issuer.
FMR LLC (parent of Fidelity Investments) and its chair Abigail P. Johnson filed Amendment No. 4 to Schedule 13G reporting a passive stake in Alignment Healthcare (ALHC).
- Shares owned: 11,279,800.70 common shares.
- Percent of class: 5.7 % as of the event date 30 Jun 2025.
- Voting power: FMR holds sole voting power over 11,277,456.23 shares; Johnson reports no direct voting power.
- Dispositive power: FMR and Johnson each have sole dispositive power over the full 11.28 m shares; no shared powers are disclosed.
The filing is made under Rule 13d-1(b)/(c), confirming the stake is held in the ordinary course of business with no intent to influence control. The signature is dated 5 Aug 2025 and executed by Richard Bourgelas under existing power of attorney.
Crossing the 5 % threshold positions Fidelity as a significant institutional shareholder, potentially broadening ALHC’s investor base and adding passive support to the stock’s float; however, the filing provides no insight into future trading intentions.
Form 4 filing for Alignment Healthcare (ALHC) shows Director Joseph S. Konowiecki sold 25,000 common shares on 31 Jul 2025 at $16.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted 5 Mar 2025. Gross proceeds equal roughly $400k.
Following the sale, Konowiecki’s direct ownership stands at 1,152,049 shares. No derivative securities were reported. The transaction does not alter board status and no other insider activity is disclosed in this filing.
Alignment Healthcare, Inc. (ALHC) — Form 144 filing
An insider intends to sell up to 25,000 common shares (≈0.013% of the 198,031,417 shares outstanding) through broker Justin Tabit on or about 31 Jul 2025. The shares, valued at an estimated $398,750, were originally received on 6 Oct 2014 as equity awards from Joseph Konowiecki. No related sales have been made in the past three months. The filer confirms possession of no undisclosed material adverse information and notes potential reliance on a Rule 10b5-1 trading plan.
FAQ
What is the current stock price of Alignment Healthcare (ALHC)?
What is the market cap of Alignment Healthcare (ALHC)?
